Chicago Community Health Study
- Conditions
- Smoking
- Interventions
- Behavioral: Enhanced CareBehavioral: TAU
- Registration Number
- NCT04460417
- Lead Sponsor
- University of Chicago
- Brief Summary
The study examined smokers from the initial COMPASS survey who live in one of three local Census tracks with large concentrations of minority populations and smoking rates, including Washington Park (98.8% African American, 60.5% smoker), Gage Park (76.7% Hispanic, 26.7% smoker), and Bridgeport (34.5% Asian, 27.0% Hispanic, 29.3% smoker), randomizing them to receipt of treatment as usual care advice (via a pamphlet form the National Cancer Institute) versus theoretically-driven and empirically-supported smoking cessation advice session delivered in-person at the UCM.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 204
- Currently reside in either the Washington Park, Gage Park, or Bridgeport communities based on current physical address at the time of initial contact for study participation
- Identify as a current smoker (verified by self-report and exhaled carbon monoxide)
- Willing and able to sign an informed consent
- Stable residence and contact information throughout the follow-up period
- Not a current smoker
- Does not live within the pre-determined neighborhood locations
- Unable to sign informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Enhanced care Enhanced Care Participants will take part in an approximate one-hour health and smoking feedback session at the University of Chicago in Dr. King's Clinical Addictions Research Laboratory (CARL). The session will follow the Courage to Quitâ„¢ (CTQ) Roadmap program (developed by Dr. King with the Respiratory Health Association). This roadmap shorter version of the larger CTQ program has been specifically designed as an inpatient bedside or outpatient brief intervention guide to assess smoking cessation motivation, consequences of smoking, facts and myths about smoking, barriers to making a change, approved medications, de-bunking myths about medications or treatments without scientific evidence (e-cigarette, laser treatments, herbals, etc.), and gaining social support. Treatment as Usual TAU Participants will receive the National Cancer Institute (NCI) pamphlet "Clearing the Air" and access to related online resources, which includes brief advice to quit smoking and medication information.
- Primary Outcome Measures
Name Time Method Smoking reduction Past-week CPD at 1- and 6-month follow-up Change in average cigarettes per day (CPD)
Quit attempts Any reported (and serious) quit attempts since last session at 1- and 6-month follow-up Change in number of any and serious (12+hr) quit attempts
Motivation to change smoking Increases in stage of change at 1- and 6-month follow-ups Increase in motivation to change smoking behavior via smoking contemplation ladder (Biener-Abrams Contemplation Ladder) scores. Scores are on a 10-point scale from 0-10, with higher scores indicating higher motivation to quit smoking.
Nicotine Replacement Therapy (NRT) use Any reported NRT use since last session at 1- and 6- month follow-up Change in frequency of NRT use
Nicotine Replacement Therapy (NRT) knowledge More accurate knowledge about NRT at 1- and 6-month follow-ups Increase in accurate knowledge about NRT assessed by two items rated from a 1 (strongly disagree) to 7 (strongly agree) scale measuring agreement to the NRT myths, "NRT causes cancer" and "NRT is only used by weak people".
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Chicago
đŸ‡ºđŸ‡¸Chicago, Illinois, United States